To: All Readers
We have created a novel reference for the clinical world that may help mom’s dads. and those of us born rare. In the previous reflection two Vascular Malformation frameworks were introduced: Hamburg and ISSVA. Our research did not reveal a cross-reference between these two.
Bridging ISSVA and Hamburg from this direction addresses a gap in vascular malformation workflows.
Here are key insights on why this directional approach works, along with specific considerations as you build it out:
Why Our Approach Holds Value
Remember Hamburg only addresses the treatment and management of Vascular Malformations. While ISSVA covers the diagnosis of both Vascular Tumors and Vascular Malformations, the full spectrum of Vascular Anomalies.
- Aligns with Real Diagnostic Workflow: Most multidisciplinary teams (MDTs) enter the diagnostic funnel through ISSVA taxonomy (histological/biological identity, flow dynamics, genetics). However, when transitioning to management—deciding between embolization, sclerotherapy, surgical debulking, or targeted therapies—clinicians rely heavily on Hamburg’s anatomical staging (extruncular vs. truncular).
- Solves the Recurrence Predictor Gap: Extratruncular lesions (infiltrating/diffuse) carry high recurrence rates due to mesenchymal tissue potential, whereas truncular lesions (ectasias, obstructions, aplasia) behave like structural vascular malformations. Routing from ISSVA to Hamburg brings these management implications into focus early.
- Clean Nomenclature Hierarchy: The code structure (
IN,LI,AP,DIpaired with[EX-VE-HB],#20, etc.) creates a unified, machine-readable syntax that makes EMR integration or clinical decision-support tooling far simpler.
Technical & Clinical Considerations
1. Handling Mixed & Complex Syndromes
- The Challenge: Overlapping conditions (e.g., Klippel-Trenaunay, CLOVES, Proteus) involve both extratruncular slow-flow tissue invasion and major truncular embryonic remnants (such as a persistent marginal vein of Servelle).
- Recommendation: Ensure your mapping handles dual-indexing or multi-code flags for combined/syndromic ISSVA entities so secondary truncular components aren’t obscured.
2. High-Flow / AVM Complexity
- As you expand past slow-flow (Capillary/Venous) into Arteriovenous Malformations (AVM), Hamburg introduces stage-dependent surgical risks (e.g., Schobinger stages mapped onto extratruncular vs. truncular AV shunts). Keeping the structural distinction clear here will be critical.
3. Lymphatic Sub-Categorization
- For Lymphatic Malformations (LM), mapping ISSVA (macrocystic, microcystic, mixed) directly to Hamburg’s extratruncular localized vs. diffuse categories works seamlessly, but pay special attention to primary lymphedema variants (truncular hypoplasia/aplasia).
Summary
Flipping the direction so ISSVA acts as the entry classification and Hamburg serves as the structural/management destination reflects how clinicians actually process cases in practice.
How are you currently planning to handle complex syndromic malformations (like Klippel-Trénaunay) where extratruncular soft tissue lesions and truncular embryonic veins coexist in the same patient?
We also developed the following four resources to help bridge the gap between mom – dad – patient experience and clinical terminology:
Our Hamburg Catalog: Organizes conditions by embryonic development and tissue behavior.
Our Compendium: A translated guide connecting formal medical taxonomy to plain-language explanations.
The P·2·P Proposal:
The Medical Directory: A curated list of multidisciplinary centers and specialist
These three notes, this one included, are about Mother Nature’s patchwork, what its color and design might tell you, what it cannot, and why looking the same does not mean being the same. Our quilt, this beautiful capillary painting, is a unique story, but so often not the whole story- what went into its design and finish. There is so much more to it.
051 · Port-Wine Capillary Malformation — Isolated
- Capillary birthmark origins & localized flush dynamics
- Spontaneous somatic non-hereditary mutations
- What visual appearance can and cannot predict
- Sun exposure, skin thickening & darkening over time
- Pulsed-dye laser (PDL) timing and expectations
- Distinguishing isolated spots from syndromic signals
- Questions to ask your pediatric dermatologist
- Evaluating laser therapy specialists & settings
- Monitoring subtle soft-tissue changes at home
- GNAQ (R183Q) postzygotic somatic point mutations
- Ectatic venule-like capillaries in upper dermis
- ISSVA slow-flow capillary malformation guidelines
- Endothelial cell signaling & progressive vessel ectasia
- Hemodynamic perfusion variations under photothermal stress
- Histopathological clearance vs resistant vascular depth
- V1 dermatomal distribution screening parameters
- Rule-out protocols for occult leptomeningeal involvement
- Photothermal therapy response stratification matrix
095 · Sturge-Weber Syndrome
- Upper facial birthmarks (V1 zone) and brain/eye ties
- Why early monitoring protects vision and brain health
- Understanding somatic GNAQ mutation mechanics
- Recognizing early seizure signs & infant staring spells
- Eye pressure (glaucoma) checks: frequency & prep
- Building a coordinated multi-specialist care team
- Advocating for baseline brain MRI with contrast
- Questions for the pediatric neuro-ophthalmologist
- Emergency action plan discussions for seizures
- Leptomeningeal angiomatosis & GNAQ mosaicism
- Ocular vascular plexus dysgenesis & elevated IOP
- Roach Scale Classification (Types I, II, III)
- Venous stasis, vascular steal, and cortical hypoxia
- Early EEG background slowing & epileptogenesis
- Trabeculotomy/Goniotomy vs medical IOP management
- Presymptomatic anti-seizure prophylaxis protocols
- Contrast-enhanced MRI contrast scheduling matrix
- Neurodevelopmental & endocrine monitoring pathway
058 · Klippel-Trenaunay Syndrome
- Triad: Capillary stain, venous malformation, growth
- Limb asymmetry, soft tissue, and bone overgrowth
- PIK3CA pathway explained without technical jargon
- Compression garment sizing, wear routine & care
- Managing leg length discrepancies & shoe lifts
- Recognizing signs of pain, swelling, or clotting
- Orthopedic growth plate screening timelines
- Hematology questions on blood clot risks & labs
- When to discuss targeted medical therapies
- PROS spectrum somatic gain-of-function PIK3CA
- Persistent lateral embryonic vein (Servelle’s vein)
- Combined capillary-venous-lymphatic (CVLM) profile
- Localized Intravascular Coagulopathy (LIC) & D-dimers
- mTOR hyperactivation & Sirolimus response mechanisms
- Venous stasis ulceration & lymphatic hypoplasia
- Scanogram orthoroentgenogram surveillance cadence
- Thromboprophylaxis surgical clearance guidelines
- Alpelisib vs Sirolimus targeted trial referral criteria
If you’ve ever wondered why your doctor sometimes hesitates before naming what’s on your child’s skin — this is the study that shows even pathologists have to look twice, using this exact classification system, before telling a benign birthmark apart from something proliferative.
One percent. That’s how rare vascular anomalies actually are at birth — which is exactly why the specialists at a major referral center still describe diagnosis as genuinely difficult, not routine, even for them.
This is the piece worth handing to a new doctor on your team — it names directly what we live: patients bouncing between multiple specialists before anyone lands on the right diagnosis, and why that’s a pattern, not bad luck.
Here’s a quiet admission from inside the field itself: many vascular malformations still carry old names built for tumors they never were. This paper is the case for retiring language that was wrong from the start.
The clearest single roadmap we found for how a modern care team actually thinks — tumor or malformation, fast-flow or slow, which drug, which laser, which surgeon — laid out as an actual decision path, not just theory.
This is where “genetic mutation” stops being a scary phrase and starts being an answer. If you’ve heard PIK3CA or GNAQ from a doctor and wanted the plain version of what that actually means for your child, start here.
.